Disc Medicine (IRON) Assets (2020 - 2026)
Disc Medicine (IRON) posted quarterly Assets of $735.1 million for Q2 2026, up 10.53% year-over-year from $665.1 million in Q2 2025, and down 2.02% quarter-over-quarter from $750.2 million in Q1 2026.
Analysis
Disc Medicine (IRON) Assets (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Assets for 7 consecutive years, with $735.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets rose 10.53% year-over-year to $735.1 million; the TTM figure through Jun 2026 stood at $735.1 million (up 10.53% YoY), while the FY2025 annual figure was $806.9 million, up 62.42% from the prior year.
- Assets declined to $735.1 million in Q2 2026 per IRON's latest filing, from $750.2 million in the prior quarter.
- Across five years, Assets topped out at $806.9 million in Q4 2025 and bottomed at $106.0 million in Q3 2022.
- Historically, Assets has averaged $448.3 million across 5 years, with a median of $439.7 million in 2023.
- Annual changes were most pronounced in 2022 — Assets tumbled 34.37% — and 2023, when it soared 255.08%.
- Disc Medicine's Assets stood at $200.2 million in 2022, then jumped by 83.81% to $368.0 million in 2023, then soared by 34.99% to $496.8 million in 2024, then jumped by 62.42% to $806.9 million in 2025, then dropped by 8.9% to $735.1 million in 2026.
- Business Quant data shows IRON's Assets at $735.1 million in Q2 2026, $750.2 million in Q1 2026, and $806.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Disc Medicine | 3.06 Bn | 3.06 Bn | - | 735.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 735.07 Mn |
| Mar 31, 2026 | 750.21 Mn |
| Dec 31, 2025 | 806.88 Mn |
| Sep 30, 2025 | 630.46 Mn |
| Jun 30, 2025 | 665.06 Mn |
| Mar 31, 2025 | 709.27 Mn |
| Dec 31, 2024 | 496.77 Mn |
| Sep 30, 2024 | 495.15 Mn |
| Jun 30, 2024 | 510.22 Mn |
| Mar 31, 2024 | 354.18 Mn |
| Dec 31, 2023 | 368.00 Mn |
| Sep 30, 2023 | 376.50 Mn |
| Jun 30, 2023 | 384.17 Mn |
| Mar 31, 2023 | 243.78 Mn |
| Dec 31, 2022 | 200.21 Mn |
| Sep 30, 2022 | 106.03 Mn |
| Jun 30, 2022 | 113.33 Mn |
| Mar 31, 2022 | 124.29 Mn |
| Dec 31, 2021 | 92.41 Mn |
| Sep 30, 2021 | 155.54 Mn |